-
Moving cancer therapy forward: Engineered antibodies for the treatment of B-cell malignancies
van der Horst, H. J., 2 Nov 2021, Amsterdam: s.n.. 204 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
-
Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies
Van der Horst, H. J., de Jonge, A. V., Hiemstra, I. H., Gelderloos, A. T., Berry, D. R., Hijmering, N. J., de Jong, D., Chamuleau, M. E. D., Zweegman, S., Breij, E. C. W., Roemer, M. G. M. & Mutis, T., 13 Nov 2019, In: Blood. 134Research output: Contribution to journal › Meeting Abstract › Academic
-
The Impact and Modulation of Microenvironment-Induced Immune Resistance Against CAR T Cell and Antibody Treatments in Multiple Myeloma
Holthof, L. C., Van der Horst, H. J., Poels, R., van der Schans, J. T., Gelderloos, A. T., Li, F., Lokhorst, H., Zweegman, S., Themeli, M., Van de Donk, N. W. C. J., Groen, R. W. J. & Mutis, T., 13 Nov 2019, In: Blood. 134Research output: Contribution to journal › Meeting Abstract › Academic
- All publications
